Two microsatellite repeat polymorphisms in the EPO gene

Same author

Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Same author

Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm.

Drugs of today (Barcelona, Spain : 1998)·2020

Same author

Adaptive genetic changes related to haemoglobin concentration in native high-altitude Tibetans.

Experimental physiology·2015

Same author

Presence of polyclonal hematopoiesis in females with Ph-negative myeloproliferative neoplasms.

Leukemia·2015

Same author

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes.

Blood cancer journal·2015

Same author

End-tidal carbon monoxide as an indicator of the hemolytic rate.

Blood cells, molecules & diseases·2015

Same journal

Nucleic acid-based therapeutic strategies for modulator-refractory cystic fibrosis-causing variants.

Human molecular genetics·2026

Same journal

Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.

Human molecular genetics·2026

Same journal

Nicotinamide riboside prevents mitochondrial dysfunction in nemaline myopathy type 6.

Human molecular genetics·2026

Same journal

Retraction: Aqua-soluble DDQ reduces the levels of Dr1 and Ab and inhibits abnormal interactions between Ab and Dr1 and protects Alzheimer's disease neurons from Ab- and Dr1-induced mitochondrial and synaptic toxicities.

Human molecular genetics·2026

Same journal

Retraction: Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss.

Human molecular genetics·2026

Same journal

Editor's Note: Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.

Human molecular genetics·2026

Related Experiment Videos

Two microsatellite repeat polymorphisms in the EPO gene

Related Concept Videos

Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial.

Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm.

Adaptive genetic changes related to haemoglobin concentration in native high-altitude Tibetans.

Presence of polyclonal hematopoiesis in females with Ph-negative myeloproliferative neoplasms.

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes.

End-tidal carbon monoxide as an indicator of the hemolytic rate.

Nucleic acid-based therapeutic strategies for modulator-refractory cystic fibrosis-causing variants.

Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.

Nicotinamide riboside prevents mitochondrial dysfunction in nemaline myopathy type 6.

Retraction: Aqua-soluble DDQ reduces the levels of Dr1 and Ab and inhibits abnormal interactions between Ab and Dr1 and protects Alzheimer's disease neurons from Ab- and Dr1-induced mitochondrial and synaptic toxicities.

Retraction: Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss.

Editor's Note: Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.

Related Experiment Videos

Two microsatellite repeat polymorphisms in the EPO gene

Related Concept Videos

Related Articles

Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial.

Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm.

Adaptive genetic changes related to haemoglobin concentration in native high-altitude Tibetans.

Presence of polyclonal hematopoiesis in females with Ph-negative myeloproliferative neoplasms.

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes.

End-tidal carbon monoxide as an indicator of the hemolytic rate.

Nucleic acid-based therapeutic strategies for modulator-refractory cystic fibrosis-causing variants.

Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.

Nicotinamide riboside prevents mitochondrial dysfunction in nemaline myopathy type 6.

Retraction: Aqua-soluble DDQ reduces the levels of Dr1 and Ab and inhibits abnormal interactions between Ab and Dr1 and protects Alzheimer's disease neurons from Ab- and Dr1-induced mitochondrial and synaptic toxicities.

Retraction: Breast cancer cell-derived exosome-delivered microRNA-155 targets UBQLN1 in adipocytes and facilitates cancer cachexia-related fat loss.

Editor's Note: Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease.